- Home
- ALMU vs DERM Comparison
ALMU vs DERM Comparison
Compare ALMU & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALMU | DERM |
|---|---|---|
| Founded | 2019 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 286.8M | 257.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ALMU | DERM |
|---|---|---|
| Price | $14.33 | $7.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $25.50 | $12.67 |
| AVG Volume (30 Days) | ★ 448.0K | 128.6K |
| Earning Date | 02-11-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,229,000.00 | ★ $59,399,000.00 |
| Revenue This Year | $20.26 | $17.48 |
| Revenue Next Year | $69.09 | $55.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 92.48 | 2.82 |
| 52 Week Low | $5.69 | $4.85 |
| 52 Week High | $25.88 | $9.56 |
Technical Indicators
Market Signals| Indicator | ALMU | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 42.66 | 43.26 |
| Support Level | $15.00 | $7.57 |
| Resistance Level | $17.26 | $8.29 |
| Average True Range (ATR) | 1.25 | 0.42 |
| MACD | -0.10 | -0.11 |
| Stochastic Oscillator | 36.93 | 23.69 |
Price Performance
Historical ComparisonAbout ALMU Aeluma Inc.
Aeluma Inc is a semiconductor company specializing in sensors and communications. It is developing sensor technology for mobile devices and vehicles. The company develops novel optoelectronic devices for sensing and communications applications. The company manufactures devices using high-performance compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass-market microelectronics. The applications include mobile, automotive, AI, defense & aerospace, communication, AR/VR and quantum computing.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.